Quantitative analysis of the supporting policies for pharmaceutical science and technology innovative enterprises in China
10.3969/j.issn.1673-9701.2024.13.014
- VernacularTitle:中国医药科技型创新企业支持政策量化分析
- Author:
Qianqian ZHAO
1
;
Keyu CHEN
;
Longping YANG
;
Zekun LIU
;
Juntao YANG
;
Qing LI
Author Information
1. 中国医学科学院/北京协和医学院卫生健康管理政策学院,北京 100730
- Keywords:
Pharmaceutical science and technology innovative enterprises;
Innovation and development;
Policy tools;
Policy formulation;
Quantitative analysis
- From:
China Modern Doctor
2024;62(13):51-55
- CountryChina
- Language:Chinese
-
Abstract:
Objective Based on the framework of"quantitative analysis of supporting policies",this study focuses on the formulation and implementation of supporting policies for pharmaceutical science and technology innovative enterprises in China,so as to provide a certain reference for the implementation and improvement of policies for pharmaceutical science and technology innovative enterprises in China.Methods This study used Roy Rothwell and Walter Zegveld's innovative policy tools as the basis for analysis,and combined with the dimension of policy type,the policy was quantitatively analyzed.Results A total of 47 effective policy documents were selected,including 22 issued by the state and 25 issued by Beijing municipal government.A total of 104 policy instruments were included through the dismantling of policy provisions.Specifically,environment-based policy tools accounted for the highest proportion(60.58%),while demand-based and supply-based policy tools were relatively few.From the perspective of policy types,there were more planning policy documents(25 articles),while there were relatively few specific implementation policies(22 articles).Conclusion It is necessary to focus on optimizing the formulation stage of support policies and improving the use of supply-oriented and demand-oriented policy tools to better meet the needs of pharmaceutical science and technology innovative enterprises.
